MNCs Look To China For Fresh R&D Models, Different Approaches
This article was originally published in PharmAsia News
Executive Summary
China’s pharma market offers a chance to try out new R&D models and a different approach to doing business, but local partners are required, said speakers during the inaugural Shanghai CEO Conference.